Characterization of Cannabis Use by Patients with Myotonic Dystrophy Type 1: a pilot study

Myotonic dystrophy type 1 (DM1) is a multisystemic neuromuscular disease characterized by the presence of progressive muscle weakness and myotonia [1]. Patients also often report pain, fatigue, impaired sleep and diverse functional limitations among other symptoms [2]. The treatment of DM1 is mostly symptomatic as there is no disease-modifying therapy yet available. However, some symptoms are amenable to treatment but with mixed results including myotonia and pain.

Source: Neuromuscular Disorders - January 9, 2021 Category: Neurology Authors: William Beauchesne, Catherine Savard, Marika C ôté-Hamel, Émilie Poliquin, Valérie Gagné-Ouellet, Cynthia Gagnon, Karine Tremblay Source Type: research